广发鑫享混合A

Search documents
长白山股价涨5.05%,广发基金旗下1只基金重仓,持有131.01万股浮盈赚取340.62万元
Xin Lang Cai Jing· 2025-09-04 03:31
9月4日,长白山涨5.05%,截至发稿,报54.10元/股,成交8.33亿元,换手率5.99%,总市值144.27亿 元。长白山股价已经连续5天上涨,区间累计涨幅20.33%。 从基金十大重仓股角度 资料显示,长白山旅游股份有限公司位于吉林省长白山保护开发区池北区(白林西区和平街),成立日期 2010年12月8日,上市日期2014年8月22日,公司主营业务涉及旅游服务业,包括旅游客运、旅行社及温 泉水开发、利用业务。主营业务收入构成为:旅游客运72.31%,酒店18.79%,其他4.52%,旅行社 4.01%,其他(补充)0.36%。 数据显示,广发基金旗下1只基金重仓长白山。广发鑫享混合A(002132)二季度持有股数131.01万股, 占基金净值比例为2.67%,位居第九大重仓股。根据测算,今日浮盈赚取约340.62万元。连续5天上涨期 间浮盈赚取1139.77万元。 从长白山十大流通股东角度 数据显示,广发基金旗下1只基金位居长白山十大流通股东。广发鑫享混合A(002132)二季度新进十 大流通股东,持有股数131.01万股,占流通股的比例为0.49%。根据测算,今日浮盈赚取约340.62万 元。连续5 ...
广发兴诚混合A近三年跑输业绩基准56% 郑澄然面临降薪压力
Xin Lang Ji Jin· 2025-05-23 13:43
Core Viewpoint - The China Securities Regulatory Commission (CSRC) has introduced a new action plan aimed at promoting high-quality development of public funds, which includes a performance-based compensation mechanism for fund managers linked to long-term performance [1] Group 1: Regulatory Changes - The new action plan specifies that if a fund manager's product underperforms its benchmark by more than 10 percentage points over three years, their performance compensation will be significantly reduced [1] - Conversely, if the performance exceeds the benchmark, the compensation may be increased [1] Group 2: Fund Performance Analysis - The Guangfa Xingcheng Mixed A fund has shown long-term poor performance, with a cumulative return over the past three years that is 51.12% lower than its benchmark [2] - As of May 20, 2025, the fund's total assets have decreased from a peak of 4.863 billion to 1.262 billion [5] - The fund manager, Zheng Chengran, has a return of -59.05% during his tenure, which has lasted over four years [4] Group 3: Investment Strategy and Holdings - The fund has heavily invested in the photovoltaic industry, with top holdings including leading companies such as Sungrow Power Supply (8.38%) and Hengtong Optic-Electric (8.02%) [6][9] - Despite attempts to diversify into other sectors like agriculture and pharmaceuticals, the fund's performance has continued to decline, indicating a lack of effective strategy [10][12] Group 4: Market Dynamics and Future Outlook - The fund's strategy has been characterized by frequent shifts without a clear guiding logic, leading to a fragmented approach that has not mitigated losses in the renewable energy sector [12][13] - Zheng Chengran expressed optimism about potential recovery in the renewable energy sector and the pharmaceutical industry, citing recent market stability and sector rotation [14]